3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Pancreatic Ductal
1
Interventions
Gemcitabine
5
MK-4721
2
130-nm albumin-bound paclitaxel
2
selinexor
1
relacorilant
1
ponatinib
1
neratinib
1
folfirinox
1
contrast agent BR1
1
cobimetinib
1
ceritinib
1
brigatinib
1
abemaciclib
1
S 1 (combination)
1
Radiotherapy
1
Radiosurgery
1
Paclitaxel
1
PEGPH20
1
Oxaliplatin
1
Irinotecan
1
Floxuridine
1
Etoposide
1
Enoxaparin
1
Drug Therapy
1
Doxorubicin
1
Dexamethasone
1
Colchicine
1
Capecitabine
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Pancreatic Ductal
×
contrast agent BR1
×
Clear all
NCT04146441
2023-01-19
PDAC
St. Olavs Hospital
Phase 2
Completed
20 enrolled